Researchers Identify Immune Protein as Key Driver of Age-Related Inflammation, Pointing Toward Potential Anti-Aging Treatments
A research team has identified a specific immune protein that appears to play a central role in driving chronic inflammation as the body ages. The protein, known as C3, was found to decrease in response to moderate calorie restriction, a well-known dietary intervention associated with extended lifespan and improved health in various organisms.
The study found that blocking C3 directly reduced age-related inflammation in mouse models, raising intriguing possibilities for future therapeutic approaches. If these findings translate to humans, treatments targeting C3 could potentially offer some of the anti-aging benefits of calorie restriction without requiring people to follow severely restricted diets.
Chronic inflammation increases with age and is linked to numerous age-related diseases, including cardiovascular conditions, metabolic disorders, and cognitive decline. By identifying C3 as a key contributor to this inflammatory process, researchers have opened a new avenue for developing interventions that could help people age more healthily.
The findings represent early-stage research, and further studies will be needed to determine whether targeting C3 in humans would produce similar effects without unintended side effects.